GreenBE Pharma - About the company
GreenBE Pharma is an unfunded company based in Elvas (Portugal), founded in 1831. It operates as a Producer of medicinal cannabis for the pharmaceutical industry. GreenBE Pharma has not raised any funding yet. The company has 275 active competitors, including 18 funded and 20 that have exited. Its top competitors include companies like Aragen, OneSource and Kardigan.
Company Details
Producer of medicinal cannabis for the pharmaceutical industry. This company cultivates and processes medicinal cannabis plants sustainably, creating tailor-made solutions for pharmaceutical applications. Their production process encompasses breeding programs, cultivation, processing, extraction and purification, packaging, and quality control. The company develops innovative products and systems to maximize production efficiency, focusing on improving patient quality of life through treatments for chronic or neurodegenerative diseases and cancer.
Key Metrics
Sign up to download GreenBE Pharma's company profile
GreenBE Pharma's funding and investors
GreenBE Pharma has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
GreenBE Pharma's Competitors and alternates
Top competitors of GreenBE Pharma include Aragen, OneSource and Kardigan. Here is the list of Top 10 competitors of GreenBE Pharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of drug discovery, clinical development, manufacturing, and other services for small molecules | $161M | 68/100 | ||
2nd | Pharmaceutical contract development and manufacturing organization offering pharmaceutical products | $155M | 59/100 | ||
3rd | Kardigan 2023, San Francisco (United States), Series B | Biotech company developing personalized medicines for cardiovascular diseases | $554M | 57/100 | |
4th | Developer of generics, nutraceuticals, and APIs | - | 54/100 | ||
5th |  Vectura 1997, Chippenham (United Kingdom), Acquired | Developer of inhaled therapeutics for respiratory diseases | $15.2M | 54/100 | |
6th |  Wheeler Bio 2020, Oklahoma City (United States), Series A | Provider of drug research and analytical development services for multiple therapeutic areas | $103M | 52/100 | |
7th | Quotient Sciences 1990, Nottingham (United Kingdom), Acquired | Developer and manufacturer of APIs as well as finished dosage forms | - | 52/100 | |
8th | Nephron Pharmaceuticals 1937, Florida (Puerto Rico), Late Stage | Manufacturer of sterile pharmaceutical products and provider of contract manufacturing and 503B outsourcing services | $625M | 51/100 | |
9th |  Aiolos Bio 2023, Boston (United States), Acquired | Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions | $245M | 50/100 | |
10th |  revalia bio 2021, New Haven (United States), Seed | Provider of contract based drugs development services for biopharma sector | $26.8M | 50/100 | |
148th | GreenBE Pharma 1831, Elvas (Portugal), Unfunded | Producer of medicinal cannabis for the pharmaceutical industry | - | - | 16/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on GreenBE Pharma's competitors? Click here to see the top ones
GreenBE Pharma's Investments and acquisitions
GreenBE Pharma has made no investments or acquisitions yet.
News related to GreenBE Pharma
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about GreenBE Pharma
Explore our recently published companies
- Gabriel-Glas North America - Napa based, 2022 founded, Acquired company
- Turnserv - Cleveland based, 2018 founded, Late Stage company
- TRVL Counter - Hamburg based, 2002 founded, Public company
- Denis Bauer - Germany based, 2001 founded, Unfunded company
- Stella Data Recovery - Delhi based, 2017 founded, Unfunded company
- mitte Padel - Berlin based, 2024 founded, Funding Raised company
